// App-Quantinova.ai

31 : Metabolic reprogramming in ovarian cancer

Researchers

Presenter

  • JI HEE HA

Principal Investigators

  • Rangasudhagar Radhakrishnan

  • Jeremy D. Ward

  • Muralidharan Jayaraman

  • Danny N. Dhanasekaran

Medical Centers

  • OUHSC, Oklahoma City, OK

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Gynaecological cancer

  • Solid malignancies

Biomarkers

  • Glucose transporter 1

  • Hypoxia-inducible factor-1

Drug/Treatment

  • EUK-134

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A